Earnings calls

Styrenix Perfor. concall ledger

Every earnings call for STYRENIX — management tone, guidance, KPIs and promise tracking, quarter by quarter.

STYRENIX · 5 transcripts · Chemicals · latest Q3 FY26

Q3 FY26Published 02 Feb 2026Call held 02 Feb 2026

STYRENIX Q3 FY26 Earnings Call Transcript & Analysis

Standalone EBITDA₹75.7 crStandalone EBITDA Margin11.7%Standalone PAT₹44.3 cr−7% YoYStandalone Total Income₹648.8 cr−6% YoY

Standalone EBITDA ₹76 cr (+0% YoY); Standalone EBITDA Margin 11.7%; Standalone PAT ₹44 cr (−7% YoY). Standalone EBITDA margins improved by 800 bps to 11.7% in Q3 FY26.

Read full transcript & analysis

Q2 FY26Published 12 Nov 2025Call held 12 Nov 2025

STYRENIX Q2 FY26 Earnings Call Transcript & Analysis

Standalone Revenue₹615 cr−6% YoY

Standalone Revenue ₹615 cr (−6% YoY). Standalone Q2 FY26 Revenue declined 5.8% YoY to ₹615 crores.

Read full transcript & analysis

Q1 FY26Published 14 Aug 2025Call held 14 Aug 2025

STYRENIX Q1 FY26 Earnings Call Transcript & Analysis

Consolidated Revenue₹943.5 crConsolidated PAT₹51.9 cr

Consolidated Revenue ₹944 cr; Consolidated PAT ₹52 cr. Standalone Sales Volume: 51.8 KT, up 8.1% QoQ, highest ever sales.

Read full transcript & analysis

Q4 FY25Published 25 May 2025Call held 25 May 2025

STYRENIX Q4 FY25 Earnings Call Transcript & Analysis

Consolidated Revenue₹2,982 crConsolidated PAT₹235.1 crConsolidated PAT Margin6%

Consolidated Revenue (FY25) ₹2,982 cr; Consolidated PAT (FY25) ₹235 cr; Consolidated PAT Margin (Q4 FY25) 6%. Consolidated Revenue for FY25 stood at ₹2,982 crores, with a sales volume of 203 KT.

Read full transcript & analysis

Q3 FY25Published 31 Jan 2025Call held 31 Jan 2025

STYRENIX Q3 FY25 Earnings Call Transcript & Analysis

Revenue₹691 cr+43% YoYPAT₹47.7 crPAT Margin6.3%

Revenue ₹691 cr (+42% YoY); PAT ₹48 cr; PAT Margin 6.3%. Q3 FY25 Sales volume increased by 34.4% YoY to 47.5 KT.

Read full transcript & analysis